Drugs Made In America Acquisition II Ordinary Shares Total Current Liabilities

Drugs Made In America Acquisition II Ordinary Shares (DMII) currently reports a total current liabilities of $640K as of June 2026. That compares with $330K in the prior-year period — up 96.8% year over year. Use the charts on this page to explore Drugs Made In America Acquisition II Ordinary Shares's total current liabilities history and peer comparisons.

Drugs Made In America Acquisition II Ordinary Shares's total current liabilities increased from $330K to $640K — a 96.8% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Drugs Made In America Acquisition II Ordinary Shares reported $640K in total current liabilities as of June 2026. That compares with $330K in the prior-year period — up 96.8% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total current liabilities of $640K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Drugs Made In America Acquisition II Ordinary Shares, and consider following DMII for alerts when major investors trade the stock.